Several 5-alkyl, 5-alkenyl, 5-iso-alkyl, 5-halo, 5-aminomethyl and 5-carboxy derivatives of S-DABOs (dihydro-alkyl (or cyclo-alkyl)thio-benzyloxopyrimidines), DATNOs (dihydro-alkylthionaphthylmethyl-oxopyrimidines) and F2-S-DABOs (dihydro-alkyl (or cyclo-alkyl)thio-2,6-difluorobenzyl-oxopyrimidines) have been prepared and tested as anti-HIV-1 agents. S-DABO derivatives bearing at C-6 position monosubstituted phenylmethyl or heteroarylmethyl units have also been synthesized. 2-Alkylthio-3,4-dihydropyrimidin-4(3H)-one derivatives of F2-S-DABO series bearing small alkyl groups at C-5 proved to be potent inhibitors of HIV-1 replication in vitro with selectivity indexes ranging from 250 to <2500.
ArticoM (1996) Non-nucleoside anti-HIV-1 reverse transcriptase inhibitors (NNRTIs): A chemical survey from lead compounds to selected drugs for clinical trials. Il Farmaco51: 305–331.
3.
ArticoMMassaSMaiAMarongiuMEPirasGTramontanoE & La CollaP (1993) 3,4-Dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs): A new class of specific inhibitors of human immunodeficiency virus type 1. Antiviral Chemistry & Chemotherapy4: 361–368.
4.
BabaMShigetaSYuasaSTakashimaHSekiyaKUbasawaMTanakaHMiyasakaTWalkerRT & De ClercqE (1994) Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro. Antimicrobial Agents & Chemotherapy38: 688–692.
5.
BellinaRF & FostDL (1977) Acaricidal and aphicidal 2-higher alkyl-3-hydroxy-1,4-naphthoquinone carboxylic acid esters. Ger. Offen. 2641343. Chemical Abstracts87: 117721y.
6.
BernsteinJ (1955) Alcohols containing alicyclic, aryl, and hetero-cyclic substituents. U.S. Pat. 2727899. Chemical Abstracts50: 10796h.
7.
BottaMArticoMMassaSGambacortaAMarongiuMEPaniA & La CollaP (1992) Synthesis, antimicrobial and antiviral activities of isotrimethoprim and some related derivatives. European Journal of Medicinal Chemistry27: 251–257.
DanelKLarsenEPedersenEBVestergaaardBF & NielsenC (1996) Synthesis and potent anti-HIV-1 activity of novel 6-benzyluracil analogues of 1[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. Journal of Medicinal Chemistry39: 2427–2431.
10.
DanelKNielsenC & PedersenEB (1997) Anti-HIV active naphthyl analogues of HEPT and DABO. Acta Chemica Scandinavica51: 426–430.
11.
De ClercqE (1998) The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection. Antiviral Research38: 153–179.
12.
HannickSM & KishiY (1983) Improved procedure for the Blaise reaction: A short, practical ruote to the key intermediates of the saxitoxin synthesis. Journal of Organic Chemistry48: 3833–3835.
13.
HeathcockCHJenningsRA & von GeldernTW (1983) Studies directed toward the total synthesis of securinega alkaloids. Journal of Organic Chemistry48: 3428–3431.
14.
KatagiriNKatoT & NakanoJ (1982) Studies on ketene and its derivatives. CIX. Synthesis of naturally occurring anthracene-9,10-diones. Chemical Pharmaceutical Bullettin30: 2440–2448.
15.
KeenanRMcC & WeinstockJ (1991) Preparation of 4-(tetrazol-5-yl)alkenylimidazoles as angiotensin II antagonists. Eur. Pat. Appl. EP 425211. Chemical Abstracts115: 183309t.
16.
MaiAArticoMSbardellaGMassaSLoiAGTramontanoEScanoP & La CollaP (1995) Synthesis and anti-HIV-1 activity of thio analogues of dihydro-alkoxybenzyl-oxopyrimidines. Journal of Medicinal Chemistry38: 3258–3263.
17.
MaiAArticoMSbardellaGQiartaroneSMassaSLoiAGDe MontisAScintuFPutzoluM & La CollaP (1997) Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: Novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series. Journal of Medicinal Chemistry40: 1447–1454.
18.
MaiAArticoMSbardellaGMassaSNovellinoEGrecoGLoiAGTramontanoEMarongiuME & La CollaP (1999) 5-Alkyl-2-alkylthio-6-(2,6-dihalophenylmethyl)-3,4-dihydropyrimidin-4(3H)-ones: Novel potent and selective DABO derivatives. Journal of Medicinal Chemistry42: 619–627.
19.
MarongiuMEPaniAArticoMMassaSMaiA & La CollaP (1992) Selective inhibition of HIV-1 replication by a novel series of 2-substituted 6-benzyl-pyrimidines. VIII International Conference onAIDS, Amsterdam, The Netherlands, 19–24 July. PoA 2315.
20.
MassaSMaiAArticoMSbardellaGTramontanoELoiAGScanoP & La CollaP1995) Synthesis and antiviral activity of new 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), specific inhibitors of human immunodeficiency virus type-1. Antiviral Chemistry & Chemotherapy6: 1–8.
21.
MillerWHDessertAM & AndersonGW (1948) The synthesis of some 6-substituted-2-thiouracils. Journal of the American Chemical Society70: 500–502.
22.
MonostoryJ (1952) New derivatives on carbon atom 6 of 2-thiouracil with antithyroidal effects. Anales Asociaciòn Quìmica Argentina40: 99–108.
23.
PauwelsRBalzariniJBabaMSnoeckRScholsDHerdewijnPDesmysterJ & De ClercqE (1988) Rapid and automated tetrazolium-based assay for the detection of anti-HIV compounds. Journal of Virological Methods20: 309–321.
24.
SbardellaGMaiAArticoMMassaSMarcedduTVargiuLMarongiuME & La CollaP (2000) Does the 2-methylthiomethyl substituent really confer high anti-HIV-1 activity to S-DABOs?Medicinal Chemistry Research10: 30–39.
25.
TanakaHTakashimaHUbasawaMSekiyaKNittaIBabaMShigetaSWalkerRTDe ClercqE & MiyasakaT (1992) Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: Effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity. Journal of Medicinal Chemistry35: 337–345.
26.
TaniHNagakuraMMizutaniNOhtakiH & YoroiS (1974) Pyrimidine derivatives. Japan Pat. 7403 933. Chemical Abstracts81: 152264z.
27.
TramontanoEMarongiuMEDe MontisALoiAGArticoMMassaSMaiA & La CollaP (1994) Characterization of the anti-HIV-1 activity of 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), new non-nucleoside reverse transcriptase inhibitors. Microbiologica17: 269–279.
